Blogs

Omnipod 5

Be the first person to recommend this.
Omnipod 5 Now Available! The much-anticipated Insulet’s Omnipod 5 is now available! I wanted to provide an brief overview of the system: Features of the system include Smart Adjust technology to proactively adjust insulin every 5 minutes working towards a customizable target selected by the user (which can be between 110-150mg/dl). The system can have up to 8 targets during the day if the person would prefer to have the lower target overnight and slightly higher one during the day as an example. The system also includes Smart Bolus calculator which will consider the CGM blood sugar with trend (this can be in manual or automated mode). The CGM trend ...
0 comments
Be the first person to recommend this.
T2DM management complicated by gastroparesis Prepared by: Courtney Cameron, PharmD, PGY2 Ambulatory Care Pharmacy Resident, Boston Medical Center. Reviewed by: Katelyn O'Brien, PharmD, BCPS, CDCES Clinical Pharmacy Specialist, Boston Medical Center. What is diabetic gastroparesis? Gastroparesis is an autonomic neuropathic complication that more commonly affects individuals with T1DM or longstanding T2DM and may occur as a result of damaged nerves within the enteric nervous system. 1,2 It is estimated that 20-50% 3 of individuals with diabetes are affected by gastroparesis, while 30% of individuals with gastroparesis have comorbid diabetes 4 . Gastroparesis ...
0 comments
Be the first person to recommend this.
Hi everyone ADCES NJ had a great annual meeting and we have more programs in store this year moving forward I would like to thank the exhibitors/corporate sponsors that supported us at the annual meeting on May 13th Insulet, Mannkind, Ascensia, Life Scan, Novo Nordisk, Xeris, Medtronic, Dexcom, Abbott, CHC Solutions, Tandem, BD/Embecta, Astra Zeneca, Intuitive, Senior Moments Medicare solutions, Simplicity I will also like to thank the Board and the Coordinating Body for the hard work in putting the annual meeting together. This event and any other event would not be a success without you Johanna Burani (Annual meeting chair), Nancy Rhodes (Awards chair), ...
0 comments
Be the first person to recommend this.
Being a new member of ADCES has been such a wonderful experience. Not only has it brought me new friends, but it has also provided me with so much knowledge. I leave every meeting a little bit wiser regarding different aspects of this industry. I have thoroughly enjoyed being a member thus far, and plan to continue to be a member for years to come. What are some of the highlights of your time as an ADCES member? - Brigitta Fieldhammer
0 comments

Case Study - WPLNG Blog

Be the first person to recommend this.
This is an interesting patient who I recently had. Patient is a 36 year old male who developed pancreatitis in 2008 and experienced multiple flare ups over the course of 5 years. After many studies and follow-ups with specialists there was no underlying cause determined. In 2013 the patient had pancreatitis which resulted in pancreatic failure with necrotizing tissue present. Patient underwent a total pancreatectomy with islet cell transplant in 2013. Post surgery the patient required insulin short term but has not had any intervention over the last 10 years. Labs obtained: c-peptide: 0.94 ng/mL HbA1c: 6.2% Fasting glucose: 126 mg/dL Dexcom ...
1 comment
1 person recommends this.
Currently, inflation is on the rise and it could be getting harder and harder for our patients to be able to afford the tools they need to appropriately manage their diabetes. Gas prices, grocery prices, and prices on everyday necessities are increasing daily while our patient's incomes are not increasing causing burden. Below are some useful tips that educators could share on how to save money and still treat diabetes appropriately: Medications: FREE and discounted medications at Sam's Club (discounted medications with regular membership and some FREE medications with plus membership) https://www.samsclub.com/pharmacy/rxsavingsDiscounted ...
1 comment
Be the first person to recommend this.
May is mental health awareness month. Many people with diabetes and many people with disability deal with diabetes distress, depression, anxiety, or other mental health challenges. I have learned that I must ask questions and often build a different self-care plan for when their mental illness is most impacting them. I cannot have the same expectations as when they are feeling like themselves. Yet other times I must accept that the individual identifies with their disability and that they see their diagnosis as a big part of who they are. In those cases, I try to see how they identify with diabetes and how they can implement healthy behaviors. When working ...
1 comment

Free CEUs through ADCES

Be the first person to recommend this.
If you're looking for opportunities for free or low-cost CEUs, check out the ADCES resources available! Below are self-paced options that are free to ADCES members. Continuous Glucose Monitoring: Real World Case Studies in Pattern Management (4.5 hours) Putting Continuous Glucose Monitoring (CGM) into Practice: Certificate Program (7.5 hours) The Art of Telehealth (6.5 hours) Also, don't forget to register for our upcoming local programs! Are there any other good ADCES resources for CEUs you have found lately? - WPLNG Board
1 comment
Be the first person to recommend this.
Did you see the publication in JAMA Network Open on February 23, 2022 titled, “Analysis of Severe Hypoglycemia Among Adults with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease”? Key points Question: Is nonalcoholic fatty liver disease (NAFLD) associated with severe hypoglycemia in individuals with type 2 diabetes? Findings: In cohort study of more than 1.9 million individuals, participants with type 2 diabetes and NAFLD without cirrhosis had an approximately 26% increased risk of severe hypoglycemia after adjustment for multiple clinical covariants. Meaning: Knowledge of the association of NAFLD with severe hypoglycemia in adults with type 2 diabetes, ...
0 comments
Be the first person to recommend this.
FDA approves 2mg dose of Ozempic (semaglutide) for T2DM Titration: 0.25mg weekly x 4 weeks (to avoid GI side effects) 0.5mg weekly as maintenance dose, if tolerating after 4 weeks and need additional glucose control, may increase to 1mg weekly. After 4 weeks if tolerating, may increase to 2mg weekly. Dosage forms: 2mg/1.5mL pen: 0.25mg or 0.5mg doses 4mg/3mL pen: 1mg doses 8mg/3mL pen: 2mg doses Trial Data – SUSTAIN FORTE:Efficacy and Safety of once weekly semaglutide 2mg vs 1mg in patients with T2DM; double blind, randomized trial In the SUSTAIN FORTE trial, people with an average starting A1C of 8.9% treated with Ozempic ® 2 mg achieved a ...
0 comments
Be the first person to recommend this.
Diabetes and Ramadan - 2021 Practical Guidelines from International Diabetes Federation (IDF) and the Diabetes and Ramadan International Alliance (DAR) https://www.daralliance.org/daralliance/idf-dar-practical-guidelines-2021/#:~:text=A%20cornerstone%20of%20managing%20diabetes,episodes%20of%20low%20blood%20glucose . ADCES Fasting Tip Sheet: https://www.diabeteseducator.org/docs/default-source/practice/educator-tools/fasting_tip_sheet.pdf?sfvrsn=2 When is Ramadan: Saturday April 2- Sunday May 1 What is Ramadan: a holy month for Muslims during which time the consumption of food or drink is forbidden between dawn and dusk Iftar: sunset meal ...
0 comments
Be the first person to recommend this.
Depending on where you live in the United States, daylight savings time is here once again. It has pros and cons. Some people don’t like losing an hour of sleep, yet others like the extra daylight. The time change can impact circadian functions, which intern can lead to dysfunction and metabolic, behavioral and cognitive abilities. This can throw off not only sleep cycles, but blood glucose levels. If in the days and weeks to come, you are helping a person problem solve variable blood glucose levels, think about the following: 1. Did the person change the time on their insulin pump? 2. Is their body still having metabolic/hormonal changes while adjusting ...
1 comment
Be the first person to recommend this.
In a recent Huddle podcast , there continues to be a clear need for CDCES research and implementation science. Putting evidence into practice is core to the cross functional care of the patient living with diabetes and essential for positive patient outcomes. CDCES can lead clinical practice by engaging stakeholders and developing champions for this important work. Understanding the community and developing advocates for implementation science is core to successful execution in this research. Moreover, this continues to bolster the value of the CDCES role in research and impact to patient care. - WPLNG Board
0 comments
Be the first person to recommend this.
Cardiorenal Benefits of Finerenone in the Treatment of Diabetic Kidney Disease Allyson Ellsworth, PharmD Candidate, Class of 2023, Ben and Maytee Fisch College of Pharmacy Lourdes Cross, PharmD, BCACP, CDCES, Sullivan University College of Pharmacy & Health Sciences Both type 2 diabetes (T2D) and chronic kidney disease (CKD) are becoming increasingly prevalent within the United States. Currently, over twenty million adults have T2D, and 20-40% of these patients are expected to develop some form of CKD. 1 Further, kidney disease development plays a role in increased cardiovascular (CV) disease. Finerenone is a novel nonsteroidal, ...
0 comments
Be the first person to recommend this.
February is National Heart Month. High blood pressure, high cholesterol and smoking are key risk factors in this number one cause of death. Are we discussing the ABC’s with our patients in diabetes education? Heart Disease Facts | cdc.gov Million Hearts ® 2027 initiative : To optimize the possibility of preventing one million preventable CVD events in the next five years , Million Hearts ® prioritized strategies for building healthy communities and optimizing care through a committed focus on specific populations experiencing inequities. A 20% improvement in key indicators would translate to one million fewer events over a five-year period. ...
0 comments
Be the first person to recommend this.
Join the next ADCES Advocacy Townhall on Tuesday, March 29 from 1:00-2:00pm CT/ 2:00-3:00pm ET/ 11-12pm PT. No registration required. On this call, we'll be joined by representatives from Prevent Blindness who will share information around their advocacy efforts and opportunities for alignment. ADCES will also provide advocacy updates and share plans for the 2022 Public Policy Forum. We also want to invite states to share "quick fire" updates- 1 minutes or less! We invite to share legislative information from your state. We also hope to have a discussion to assess challenges and lessons learned in advocacy! This will be a presentation on Microsoft Teams. ...
0 comments
Be the first person to recommend this.
Prepared by: Devin Yu, PharmD Candidate 2022 Northeastern University Katelyn O'Brien, PharmD, BCPS, CDCES Boston Medical Center Considerations for Management of Alpelisib Induced Hyperglycemia HR-Positive, HER2-Negative Breast Cancer Breast cancer is one of the most common cancers in women, affecting approximately 250,000 women in the US and 1,000,000 women in the 8 major markets ++ . 1-9 About 73% of these patients are diagnosed with HR-positive, HER2-negative disease. Alpelisib and PI3K mutations Because the treatment landscape for HR-positive, HER-2-negative breast cancer continues to show significant and persistent unmet need, newer ...
0 comments
Be the first person to recommend this.
There is a topic that has been weighing on my mind since last week’s announcement of the FDA approval of the Omnipod 5. How do we stay updated with new devices, recalls, and current trends in the world of diabetes. Patients are finding out about new products before providers and this creates a stir with calls coming into offices requesting the latest upgrade and providers not even being aware of the approvals. How do we change this? Joining the FDA devices database ( https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/medical-device-databases ) to register for alerts on new devices and recall information, joining social media ...
0 comments
Be the first person to recommend this.
The ADCES Advocacy Committee has announced the advocacy townhall schedule for 2022. We’ll host four quarterly virtual townhall meetings, each occurring on a Tuesday at 11:00am PT/1:00pm CT/ 2:00pm ET. The dates are as follows: March 29 June 21 September 13 November 15 What’s an advocacy townhall? Advocacy holds different meanings for different people. It can mean assisting a patient navigate their insurance plan or appeal a denial. It can mean speaking to legislators about a piece of legislation. It can mean trying to make a change to your state's Medicaid plan or even demonstrating the value of diabetes care and education specialists to your hospital ...
0 comments
Be the first person to recommend this.
On January 13, 2022, the National Clinical Care Commission (NCCC) released their long-awaited final report to Congress, entitled Leveraging Federal Programs to Prevent and Control Diabetes and Its Complications , which details evidence-based recommendations to improve and streamline federal diabetes policies related to awareness, prevention and treatment programs. The report is comprehensive and covers many policy areas including addressing social determinants of health, improving affordability and accessibility, and research and awareness. ADCES advocated for inclusion of many of the recommendations. A high-level overview of key recommendations that ...
1 comment